A Multi-National, Randomised, Open-Label, Parallel, Phase III Non-Inferiority Study Comparing NK105 and Paclitaxel in Metastatic or Recurrent Breast Cancer Patients
British Journal of Cancer - United Kingdom
doi 10.1038/s41416-019-0391-z
Full Text
Open PDFAbstract
Available in full text
Date
February 12, 2019
Authors
Publisher
Springer Science and Business Media LLC